Kenneth C. Carter, President and CEO at AVALON PHARMACEUTICALS INC (AVRX), bought 4,832 shares at $2.48 ($12K) on 2008-01-23, disclosed to the SEC on 2008-01-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.46 | 100 | $246 | 2.0% |
| 2 | $2.48 | 632 | $2K | 12.6% |
| 3 | $2.49 | 500 | $1K | 10.0% |
| 4 | $2.49 | 100 | $249 | 2.0% |
| 5 | $2.54 | 100 | $254 | 2.0% |
| 6 | $2.60 | 164 |
| $426 |
| 3.4% |
| 7 | $2.60 | 800 | $2K | 16.7% |
| 8 | $2.61 | 1,036 | $3K | 21.7% |
| 9 | $2.65 | 1,400 | $4K | 29.7% |
| Total | $2.58 avg | 4,832 | $12K | 100% |
| Filing → |
| AVRX | BUY | 2006-08-24 | $7K | — | Filing → |